Perigon Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,334
Closed -$225K 841
2023
Q3
$225K Sell
11,334
-63,812
-85% -$1.21M 0.01% 697
2023
Q2
$1.41M Buy
75,146
+3,464
+5% +$69.9K 0.06% 254
2023
Q1
$1.46M Buy
71,682
+7,087
+11% +$143K 0.08% 218
2022
Q4
$1.37M Buy
+64,595
New +$1.34M 0.08% 220

Other funds holding BTAL

Perigon Wealth Management's BTAL Position: Q4 2023 in Review

Perigon Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2023, closing a stake of 11,334 shares — an estimated $225K sold.

Perigon Wealth Management first reported a position in BTAL in Q4 2022 and held it in 4 quarters. The position peaked at $1.46M in Q1 2023. 75 funds tracked by Wall St. Rank hold BTAL as of Q4 2023.

  • Perigon Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2023 after selling out during the quarter.
  • Perigon Wealth Management sold 11,334 AGF US Market Neutral Anti-Beta Fund shares in Q4 2023, an estimated $225K.
  • Perigon Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2022 and held it in 4 quarters.
  • Perigon Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $1.46M in Q1 2023.
  • 75 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2023.

Based on Perigon Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.